Sign in

CIK 0001053369

  • Non-accelerated filer
  • Smaller reporting company

ELITE PHARMACEUTICALS INC /NV/

Sign in to watch
Ticker
ELTP
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NJ
Entity type
Operating
EIN
223542636
Phone
+1 201-750-2646
Business address
165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
Former names
ELITE PHARMACEUTICALS INC /DE/
  1. 4 Open-market sale Director sold 805,583 shares at $0.18 ($147,422)
  2. 4 Open-market sale Chief Scientific Officer sold 805,583 shares at $0.18 ($147,422)
  3. 4 Open-market sale 10% owner sold 805,583 shares at $0.18 ($147,422)
  4. 4 Open-market sale 10% owner sold 805,538 shares at $0.18 ($147,413)
  5. 4 Open-market sale Director sold 531,185 shares at $0.15 ($79,678)
  6. 4 Open-market sale Chief Scientific Officer sold 531,185 shares at $0.15 ($79,678)
  7. 4 Open-market sale 10% owner sold 531,185 shares at $0.15 ($79,678)
  8. 4 Open-market sale 10% owner sold 531,185 shares at $0.15 ($79,678)
  9. 4/A Open-market sale 10% owner sold 253,050 shares at $0.12 ($29,683)
  10. 4/A Open-market sale 10% owner sold 253,050 shares at $0.12 ($29,683)
  11. 4/A Open-market sale Director sold 253,050 shares at $0.12 ($29,683)
  12. 4/A Open-market sale Chief Scientific Officer sold 253,050 shares at $0.12 ($29,683)
  13. 4/A Open-market sale 10% owner sold 253,050 shares at $0.12 ($29,683)
  14. 4/A Open-market sale 10% owner sold 253,050 shares at $0.12 ($29,683)
  15. 4 Open-market sale 10% owner sold 298,626 shares at an average $0.12 ($37,305)
  16. 4 Open-market sale Director sold 298,626 shares at an average $0.12 ($37,305)
  17. 4 Open-market sale Chief Scientific Officer sold 298,626 shares at an average $0.12 ($37,305)
  18. 4 Open-market sale 10% owner sold 298,626 shares at an average $0.12 ($37,305)
  19. 4 Returned to the company Director returned 100,000 shares (to the company)
  20. 4 Open-market sale Chief Scientific Officer sold 100,000 shares at $0.13 ($12,520)

Page 8 of 26 · 511 filings